(Q38345634)

English

DNA immunization of mice with a plasmid encoding Neisseria gonorrhea PorB protein by intramuscular injection and epidermal particle bombardment

scientific article published on January 2004

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

DNA immunization of mice with a plasmid encoding Neisseria gonorrhea PorB protein by intramuscular injection and epidermal particle bombardment (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Zhu W

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Thomas CE

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Sparling PF

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

language of work or name

0 references

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

5-6

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

660-669

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Risk of acquiring gonorrhea and prevalence of abnormal adnexal findings among women recently exposed to gonorrhea

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Antimicrobial resistance of Neisseria gonorrhoeae and emerging ciprofloxacin resistance in the Netherlands, 1991 to 1998

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Efficacy trial of a parenteral gonococcal pilus vaccine in men

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Intranasal immunization with gonococcal outer membrane preparations reduces the duration of vaginal colonization of mice by Neisseria gonorrhoeae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Structural comparison and epitope analysis of outer-membrane protein PIA from strains of Neisseria gonorrhoeae with differing serovar specificities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Gonococcal outer-membrane protein PIB: comparative sequence analysis and localization of epitopes which are recognized by type-specific and cross-reacting monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Gonococcal porin vaccine evaluation: comparison of Por proteosomes, liposomes, and blebs isolated from rmp deletion mutants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Antibody-antigen specificity in the immune response to infection with Neisseria gonorrhoeae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Epidemiologic evidence for the development of serovar-specific immunity after gonococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Longitudinal evaluation of serovar-specific immunity to Neisseria gonorrhoeae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Vaccines for gonorrhea: where are we on the curve?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Immunoglobulin G antibodies directed against protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Human experimentation with Neisseria gonorrhoeae: rationale, methods, and implications for the biology of infection and vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Characterization of a subunit structure and stability of the recombinant porin from Neisseria gonorrhoeae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Antibodies to N‐terminal peptides of gonococcal porin are bactericidal when gonococcal lipopolysaccharide is not sialylated

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

C4bp binding to porin mediates stable serum resistance of Neisseria gonorrhoeae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Antigen levels and antibody titers after DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Biological features of genetic immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Gene vaccination: plasmid DNA is more than just a blueprint

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Nucleic acid vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Comparison of nucleic acid and protein immunization for induction of antibodies specific for HIV-1 gp120

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

DNA vaccination favours memory rather than effector B cell responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Immunogenicity of the Brucella melitensis recombinant ribosome recycling factor-homologous protein and its cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Epitope specificity of antibodies raised against enterotoxigenic Escherichia coli CFA/I fimbriae in mice immunized with naked DNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Immune protection against staphylococcal enterotoxin-induced toxic shock by vaccination with a Venezuelan equine encephalitis virus replicon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Mucosal immunity in the genital tract: prospects for vaccines against sexually transmitted diseases--a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

CpG motifs as immune adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Polynucleotide vaccines in animals: enhancing and modulating responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Construction of isogenic gonococci with variable porin structure: effects on susceptibility to human serum and antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Stimulation of human leukocytes by protein II+ gonococci is mediated by lectin-like gonococcal components

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993 to 1998

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

based on heuristic

inferred from DOI database lookup

Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

based on heuristic

inferred from DOI database lookup

Monoclonal antibodies to outer membrane protein PII block interactions of Neisseria gonorrhoeae with human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

based on heuristic

inferred from DOI database lookup

Gonococci possessing only certain P.II outer membrane proteins interact with human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.08.036

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2003.08.036

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38345634&oldid=1755374136"